MetaADEDB 2.0 @ LMMD
N-carbamylglutamate
(LCQLHJZYVOQKHU-VKHMYHEASA-N)
Structure
SMILES
OC(=O)CC[C@@H](C(=O)O)NC(=O)N
Type(s)
Approved
ATC code(s)
A16AA05
Molecular Formula:
C6H10N2O5
Molecular Weight:
190.154
Log P:
0.0639
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
4
TPSA:
129.72
CAS Number(s):
1188-38-1
Synonym(s)
1.
N-carbamylglutamate
2.
N-carbamoyl-L-glutamate
3.
N-carbamoylglutamate
4.
carbamylglutamate
External Link(s)
MeSHC006895
PubChem Compound121396
ChEBI71028
CHEMBLCHEMBL1201780
DrugBankDB06775
DrugCentral3068
IUPHAR/BPS Guide to PHARMACOLOGY7458
KEGGcpd:C05829
dr:D07130
Therapeutic Target DatabaseD0Z0MG
ZINC1530283
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1VomitingFAERS: 33
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2Ammonia increasedFAERS: 30US FAERS
3PancreatitisFAERS: 10US FAERS
4NasopharyngitisFAERS: 9SIDER
US FAERS
5Product dose omissionFAERS: 8US FAERS
6NauseaFAERS: 7US FAERS
7Drug ineffectiveFAERS: 5US FAERS
8MalaiseFAERS: 4US FAERS
9AcidosisFAERS: 3US FAERS
10ConstipationFAERS: 3US FAERS
11DehydrationFAERS: 3US FAERS
12DysgeusiaFAERS: 3SIDER
US FAERS
13InfectionFAERS: 3SIDER
US FAERS
14InfluenzaFAERS: 3SIDER
US FAERS
15PneumoniaFAERS: 3SIDER
US FAERS
16SepsisFAERS: 3US FAERS
17Abdominal PainFAERS: 2SIDER
US FAERS
18AlopeciaFAERS: 2US FAERS
19Cerebrovascular accidentFAERS: 2US FAERS
20Disease ProgressionFAERS: 2US FAERS
21DizzinessFAERS: 2US FAERS
22FatigueFAERS: 2US FAERS
23GastrostomyFAERS: 2US FAERS
24HeadacheFAERS: 2SIDER
US FAERS
25Increased bronchial secretionFAERS: 2US FAERS
26Stoma site inflammationFAERS: 2US FAERS
27Urinary tract infectionFAERS: 2US FAERS
28Urine ketone body presentFAERS: 2US FAERS
29Acute respiratory failureFAERS: 1US FAERS
30Ammonia decreasedFAERS: 1US FAERS
31Blood electrolytes abnormalFAERS: 1US FAERS
32Blood ketone body increasedFAERS: 1US FAERS
33Bowel movement irregularityFAERS: 1US FAERS
34Clostridium difficile infectionFAERS: 1US FAERS
35CryingFAERS: 1US FAERS
36Device occlusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Disease complicationFAERS: 1US FAERS
38Drug dose omissionFAERS: 1US FAERS
39Drug ineffective for unapproved indicationFAERS: 1US FAERS
40FlatulenceFAERS: 1US FAERS
41Gastric DilatationFAERS: 1US FAERS
42Gastric infectionFAERS: 1US FAERS
43Gastroenteritis norovirusFAERS: 1US FAERS
44GastroenteritisFAERS: 1US FAERS
45Gastrointestinal sounds abnormalFAERS: 1US FAERS
46HypersensitivityFAERS: 1US FAERS
47Iatrogenic injuryFAERS: 1US FAERS
48LethargyFAERS: 1US FAERS
49Limb injuryFAERS: 1US FAERS
50Metapneumovirus infectionFAERS: 1US FAERS
51NeutropeniaFAERS: 1US FAERS
52Perforation of great vesselsFAERS: 1US FAERS
53Peripheral artery bypassFAERS: 1US FAERS
54Peritoneal DialysisFAERS: 1US FAERS
55Protein urine presentFAERS: 1US FAERS
56PruritusFAERS: 1US FAERS
57RetchingFAERS: 1US FAERS
58SomnolenceFAERS: 1SIDER
US FAERS
59Spinal fusion surgeryFAERS: 1US FAERS
60Unevaluable eventFAERS: 1US FAERS
61Weight decreasedFAERS: 1SIDER
US FAERS
62AnorexiaSIDER
63AstheniaSIDER
64Blood and lymphatic system disordersSIDER
65BradycardiaSIDER
66DermatitisSIDER
67Ear and labyrinth disordersSIDER
68Embryo Loss31369747CTD
69Gastrointestinal PainSIDER
70InfestationSIDER
71MalnutritionSIDER
72TonsillitisSIDER
73Transaminases increasedSIDER
74nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.